FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and medicine, and concerns a stable pharmaceutical composition of methylethylpyridinone hydrochloride in the form of an infusion solution containing methylethylpyridinone hydrochloride in the amount of 0.45-0.55 %, 12-aqueous disodium phosphate in the amount of 0.079-0.081 %, sodium hydrosulphite in the amount of 0.018-0.022 %, sodium chloride in the amount of 0.723-0.731 %, and water for injections, as well as a method for preparing it.
EFFECT: pharmaceutical composition possesses high storage stability; it is applicable for parenteral introduction in neurology and cardiology.
2 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIOXIDANT PREPARATION FOR TREATMENT AND PREVENTION OF CARDIAC PATHOLOGIES IN ANIMALS | 2023 |
|
RU2818764C1 |
| HIGH-STABLE PHARMACEUTICAL FORMULATION OF LYOPHILISATE OF 3-OXYPYRIDINE AND METHYLPYRIDINE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2012 |
|
RU2504376C1 |
| COMBINATION DRUG FOR PARENTERAL ADMINISTRATION CONTAINING METHYLETHYL PYRIDINOL HYDROCHLORIDE OR SUCCINATE AND RIBOFLAVIN | 2014 |
|
RU2566725C1 |
| AQUEOUS RISPERIDONE COMPOSITIONS | 1995 |
|
RU2161965C2 |
| METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION SOLUTION BASED ON SUBSTANCE OF HUMAN GENE ENGINEERED (RECOMBINANT) INSULIN | 2004 |
|
RU2275189C1 |
| MEDICINAL AGENT ELICITING ANTIEMETIC EFFECT | 2002 |
|
RU2205634C1 |
| SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
| EYE DROPS BASED ON PHARMACEUTICALLY TOLERABLE ADDITIVE SALTS OF ACID AND METHYL ETHYL ENCEPHABOL CONTAINING COMPOSITION OF VITAMINS B | 2013 |
|
RU2528912C1 |
| METHOD FOR PRODUCING LIPID MIXTURE AND LIPOSOMAL ORAL ANTIVIRAL THERAPEUTIC AND PROPHYLACTIC AGENT USING SAID LIPID MIXTURE | 2020 |
|
RU2746320C1 |
| ESMOLOL-BASED PREPARATION | 2002 |
|
RU2286774C2 |
